Multiple Nevi
Showing 26 - 50 of >10,000
Helicobacter Pylori Infection Trial in Chang chun (TNP-2198, Rabeprazole Sodium, Amoxicillin)
Completed
- Helicobacter Pylori Infection
- TNP-2198
- +2 more
-
Chang chun, Jilin, ChinaThe First Hospital of Jilin University
Oct 7, 2023
Asthma Trial (XKH001 Injection, XKH001 Placebo Injection)
Not yet recruiting
- Asthma
- XKH001 Injection
- XKH001 Placebo Injection
- (no location specified)
Aug 13, 2023
Multiple Sclerosis Trial in Hamburg (levidex, Control, treatment as usual (TAU))
Not yet recruiting
- Multiple Sclerosis
- levidex
- +2 more
-
Hamburg, GermanyGAIA AG
Oct 19, 2023
Rheumatoid Arthritis, Systemic Lupus Erythematosus Trial (GS-0272, Placebo)
Not yet recruiting
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- GS-0272
- Placebo
- (no location specified)
Sep 4, 2023
Drug Drug Interaction Trial in Porto (Givinostat)
Completed
- Drug Drug Interaction
-
Porto, PortugalHospital da Prelada, 3rd Floor & East Wing 4th Floor Rua Sarment
May 5, 2023
Allergic Rhinitis Due to Weed Pollen, Allergic Rhinitis Trial in Melbourne (INI-2004, Placebo)
Recruiting
- Allergic Rhinitis Due to Weed Pollen
- Allergic Rhinitis
- INI-2004
- Placebo
-
Melbourne, Victoria, AustraliaNucleus Network Pty Ltd
Sep 7, 2023
Prognosis Based on cfDNA Methylation in Multiple Myeloma
Recruiting
- Multiple Myeloma
- cfDNA methylation assessment
-
Tianjin, Tianjin, ChinaNational Clinical Research Center for Blood Diseases, Blood Dise
Jan 11, 2023
Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix, Jacksonville, Rochester
Recruiting
- Plasma Cell Myeloma
- +3 more
- Bone Marrow Biopsy
- +3 more
-
Phoenix, Arizona
- +2 more
Jan 18, 2023
Mitochondrial Dysfunction in Primary Progressive Multiple
Recruiting
- Multiple Sclerosis
-
Milan, MI, Italy
- +1 more
Aug 29, 2023
Hepatitis B, Chronic Trial in Jilin (AHB-137 injection, Placebo)
Recruiting
- Hepatitis B, Chronic
- AHB-137 injection
- Placebo
-
Jilin, ChinaThe First Hospital of Jilin University
Nov 2, 2023
Atherosclerotic Cardiovascular Disease Trial (YN001, Placebo for YN001, rosuvastatin calcium tablets)
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- YN001
- +2 more
- (no location specified)
Sep 21, 2023
Multiple Sclerosis, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)
Not yet recruiting
- Multiple Sclerosis
- +2 more
- Patient Participation Form
- (no location specified)
Feb 25, 2023
Healthy Trial in Alcorcón (Mechanical Conditioning stimulus)
Recruiting
- Healthy
- Mechanical Conditioning stimulus
-
Alcorcón, Madrid, SpainUniversidad Rey Juan Carlos
Feb 15, 2023
Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)
Not yet recruiting
- Multiple Myeloma
- Myeloma-Associated Amyloidosis
- Selinexor
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Apr 6, 2023
Multiple Myeloma Trial in Duarte (Biospecimen Collection, Bone Marrow Aspiration, Computed Tomography)
Recruiting
- Multiple Myeloma
- Biospecimen Collection
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 21, 2023
Orofacial Pain in Multiple Sclerosis
Recruiting
- Multiple Sclerosis
- Diagnosis of pain
-
Varaždin, CroatiaVarazdin General Hospital
Sep 5, 2023
Determine the Optimal Initial Therapy for Multiple Myeloma
Recruiting
- Multiple Myeloma
- Non-Interventional Study
-
Scottsdale, Arizona
- +3 more
Nov 22, 2023
Drug Interaction Trial in Beijing (ZX-7101A, Oseltamivir, ZX-7101A and Oseltamivir)
Recruiting
- Drug Interaction
- ZX-7101A
- +2 more
-
Beijing, Beijing, ChinaPeking University Third Hospital
Sep 21, 2023
Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Sumida City (CCX168, Placebo)
Completed
- Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
- CCX168
- Placebo
-
Sumida City, Tokyo, JapanSumida Hospital, SOUSEIKAI Global Clinical Research Center
Aug 4, 2023
Multiple Myeloma Trial in Tucson (Immediate yoga intervention, Delayed yoga intervention)
Not yet recruiting
- Multiple Myeloma
- Immediate yoga intervention
- Delayed yoga intervention
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Sep 27, 2023
Aromatherapy, Randomized Controlled Trial, Multiple Sclerosis Trial in Erzurum (lavender oil)
Active, not recruiting
- Aromatherapy
- +2 more
- lavender oil
-
Erzurum, TurkeyAtaturk Unıversity
Jun 29, 2023
Ofatumumab in Portuguese Multiple Sclerosis Patients
Not yet recruiting
- Relapsing Multiple Sclerosis
- Ofatumumab
- (no location specified)
Mar 30, 2023